Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng Lv

Showing results (451-460 of 465) with videos related to

Pageof 47
Sort By:
Vaccines|November 26, 2025
Adjuvanted Recombinant Hemagglutinin Vaccine Provides Durable and Broad-Spectrum Immunogenicity in MiceRui Yu, Yan Guo, Senyan Zhang, et al.
Transplantation and Cellular Therapy|May 22, 2026
Impact of concurrent graft-versus-host disease on long-term survival in critically ill patients following allogeneic hematopoietic stem cell transplantation for hematological malignanciesZhixue Li, Peng Zhao, Gang Zhou, et al.
Human Immunology|June 12, 2018
Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center studyMing-Rui Huo, Ya-Jing Xu, Shu-Zhen Zhai, et al.
Journal of Thrombosis and Haemostasis : JTH|December 13, 2025
Thrombotic thrombocytopenic purpura following allogeneic hematopoietic stem cell transplantation: a rare but fatal complicationZhixue Li, Peng Zhao, Haixia Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2018
Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete RemissionMeng Lv, Yu Wang, Ying-Jun Chang, et al.
Clinical Transplantation|July 21, 2025
Incidence, Risk Factors, and Impact on Transplant Outcomes of Cytokine Release Syndrome After Infusion of Haploidentical Stem Cells With Anti-Thymocyte GlobulinFeng-Mei Zheng, Jun Kong, Jing-Zhi Wang, et al.
Bone Marrow Transplantation|November 6, 2024
Pre-transplant disease burden rather than age or donor type was associated with survival of hematopoietic cell transplantation for elderly patients with acute myeloid leukemiaRui Ma, Yi Liao, Xiao-Hui Zhang, et al.
Transplantation and Cellular Therapy|December 27, 2023
Prognostic Factors and Outcomes in Patients With Septic Shock After Allogeneic Hematopoietic Stem Cell TransplantationQiu-Sha Huang, Tian-Xiao Han, Hai-Xia Fu, et al.
Bone Marrow Transplantation|November 27, 2023
Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationQiu-Sha Huang, Tian-Xiao Han, Qi Chen, et al.
Cancer|August 13, 2025
Peritransplant lysine methyltransferase 2a-rearranged measurable residual disease dynamics as a prognostic marker in adult acute myeloid leukemiaLu-Lu Wang, Peng Zhao, Jing Liu, et al.
Pageof 47

Showing results (451-460 of 465) with videos related to

Sort By:
Pageof 47
Vaccines|November 26, 2025
Adjuvanted Recombinant Hemagglutinin Vaccine Provides Durable and Broad-Spectrum Immunogenicity in MiceRui Yu, Yan Guo, Senyan Zhang, et al.
Transplantation and Cellular Therapy|May 22, 2026
Impact of concurrent graft-versus-host disease on long-term survival in critically ill patients following allogeneic hematopoietic stem cell transplantation for hematological malignanciesZhixue Li, Peng Zhao, Gang Zhou, et al.
Human Immunology|June 12, 2018
Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center studyMing-Rui Huo, Ya-Jing Xu, Shu-Zhen Zhai, et al.
Journal of Thrombosis and Haemostasis : JTH|December 13, 2025
Thrombotic thrombocytopenic purpura following allogeneic hematopoietic stem cell transplantation: a rare but fatal complicationZhixue Li, Peng Zhao, Haixia Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2018
Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete RemissionMeng Lv, Yu Wang, Ying-Jun Chang, et al.
Clinical Transplantation|July 21, 2025
Incidence, Risk Factors, and Impact on Transplant Outcomes of Cytokine Release Syndrome After Infusion of Haploidentical Stem Cells With Anti-Thymocyte GlobulinFeng-Mei Zheng, Jun Kong, Jing-Zhi Wang, et al.
Bone Marrow Transplantation|November 6, 2024
Pre-transplant disease burden rather than age or donor type was associated with survival of hematopoietic cell transplantation for elderly patients with acute myeloid leukemiaRui Ma, Yi Liao, Xiao-Hui Zhang, et al.
Transplantation and Cellular Therapy|December 27, 2023
Prognostic Factors and Outcomes in Patients With Septic Shock After Allogeneic Hematopoietic Stem Cell TransplantationQiu-Sha Huang, Tian-Xiao Han, Hai-Xia Fu, et al.
Bone Marrow Transplantation|November 27, 2023
Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationQiu-Sha Huang, Tian-Xiao Han, Qi Chen, et al.
Cancer|August 13, 2025
Peritransplant lysine methyltransferase 2a-rearranged measurable residual disease dynamics as a prognostic marker in adult acute myeloid leukemiaLu-Lu Wang, Peng Zhao, Jing Liu, et al.
Pageof 47